BSE: 540743 | NSE: GODREJAGRO | Animal Feed | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that Godrej Agrovet Ltd is a good quality company.
The key valuation ratios of Godrej Agrovet Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Godrej Agrovet Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation Index Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 31.8% | 22.8% | 26.6% | 23.9% | 26.4% | 17.2% | 18.1% | 17.6% | 12.7% | 15.5% | - |
| Value Creation Index ⓘ | 1.4 | 0.7 | 1.0 | 0.8 | 1.0 | 0.3 | 0.3 | 0.3 | -0.1 | 0.2 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 3,795 | 4,298 | 4,911 | 5,186 | 5,918 | 6,965 | 6,268 | 8,306 | 9,374 | 9,561 | 9,349 |
| Sales YoY Gr. | - | 13.3% | 14.3% | 5.6% | 14.1% | 17.7% | -10% | 32.5% | 12.9% | 2% | - |
| Adj EPS ⓘ | 10.3 | 9.2 | 11.8 | 11.3 | 13 | 16.3 | 16.2 | 21.3 | 12.9 | 18.6 | 21.6 |
| YoY Gr. | - | -10.8% | 27.6% | -4.1% | 14.9% | 25.7% | -0.6% | 31.3% | -39.1% | 43.9% | - |
| BVPS (₹) ⓘ | 29.2 | 35.8 | 54.4 | 73.4 | 85.7 | 95.5 | 106.6 | 117.8 | 121.3 | 130.6 | 128.3 |
| Adj Net Profit ⓘ | 191 | 170 | 217 | 216 | 249 | 313 | 311 | 408 | 249 | 358 | 416 |
| Cash Flow from Ops. ⓘ | 78.1 | 159 | 897 | 354 | 448 | 240 | -10.4 | -120 | 874 | 678 | - |
| Debt/CF from Ops. ⓘ | 4.3 | 6.5 | 0.7 | 1.2 | 0.9 | 2.7 | -94.8 | -13 | 1.5 | 1.9 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 10.8% | 10.1% | 15.1% | 2% | ||||
| Adj EPS ⓘ | 6.8% | 7.5% | 4.8% | 43.9% | ||||
| BVPSⓘ | 18.1% | 8.8% | 7% | 7.6% | ||||
| Share Price | - | 19.6% | 18.3% | 55.4% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 30.1 | 24.3 | 24.5 | 17.9 | 16.3 | 17.9 | 16 | 18.9 | 10.8 | 14.7 | 16.7 |
| Op. Profit Mgn % ⓘ | 8.1 | 7.7 | 9 | 8.6 | 7.7 | 7 | 9 | 8.1 | 5.5 | 7.4 | 8.7 |
| Net Profit Mgn % ⓘ | 5 | 3.9 | 4.9 | 4.6 | 4.5 | 4.4 | 5.5 | 5.1 | 2.6 | 3.7 | 4.5 |
| Debt to Equity ⓘ | 0.6 | 1.6 | 0.7 | 0.3 | 0.2 | 0.4 | 0.5 | 0.7 | 0.6 | 0.5 | - |
| Working Cap Days ⓘ | 0 | 105 | 111 | 107 | 105 | 104 | 122 | 107 | 101 | 90 | 48 |
| Cash Conv. Cycle ⓘ | 0 | 58 | 66 | 66 | 64 | 64 | 71 | 61 | 53 | 42 | -1 |
Return on Equity has increased versus last 3 years average to 16.70%
Sales growth is growing at healthy rate in last 3 years 15.11%
Debt to equity has declined versus last 3 years average to 0.52
Net Profit has been subdued in last 3 years 4.77%
Sales growth is not so good in last 4 quarters at -1.32%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 24.5 | 21.6 |
| TTM Sales (₹ Cr.) | 6,930 | 9,349 |
| BVPS (₹.) ⓘ | 130.5 | 128.3 |
| Reserves (₹ Cr.) ⓘ | 2,316 | 2,274 |
| P/BV ⓘ | 5.90 | 6.00 |
| PE ⓘ | 31.42 | 35.56 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 475.70 / 877.85 |
| All Time Low / High (₹) | 265.05 / 877.85 |
| Market Cap (₹ Cr.) | 14,796 |
| Equity (₹ Cr.) | 192.3 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 31.5 |
| Mar'24 | YoY Gr. Rt. % | Jun'24 | YoY Gr. Rt. % | Sep'24 | YoY Gr. Rt. % | Dec'24 | YoY Gr. Rt. % | |
|---|---|---|---|---|---|---|---|---|
| Sales (₹ Cr.)ⓘ | 2,119 | 1.4 | 2,343 | -6.2 | 2,443 | -4.8 | 2,445 | 4.4 |
| Adj EPS (₹) ⓘ | 3 | 84.5 | 7 | 28.3 | 5.8 | 6.6 | 5.8 | 21.3 |
| Op. Profit Mgn % ⓘ | 6.99 | 342 bps | 9.65 | 193 bps | 9.14 | 129 bps | 9.00 | 221 bps |
| Net Profit Mgn % ⓘ | 2.59 | 195 bps | 4.94 | 148 bps | 3.42 | -28 bps | 3.93 | 93 bps |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Particulars | Q2FY24 (Rs. Crs) | YoY Trend | Comments |
| Revenue | 2,571 | +5% | Animal feed/Palm oil segment revenues grew 5/10% resp, crop protection revenues grew 53% |
| EBITDA | 201 | +34% | |
| EBITDA Margin | 8% | +168bps | Lower material costs in animal feed and crop protection segment aided margins |
| PAT | 104 | +49% | Other income also aided profits |
Steady performance.
|
Particulars |
Q1FY24 |
YoY Trend |
Comments |
|
Revenue |
2,510 |
Flat |
Growth in animal feed and crop protection segment was masked by decline in palm oil segment |
|
EBITDA |
193 |
+19% |
|
|
EBITDA Margin |
7.69% |
+123 bps |
Softening of commodity prices in animal feed segment and higher realization in crop protection segment led to margin expansion |
|
PAT |
107 |
+21.6% |
|
Though revenues growth was not achieved overall, margin expansion sets a healthy precedence for performance ahead.
About the Company:
Godrej Agrovet (GODREJAGRO) is a significant player in the Indian agriculture sector, with a diverse portfolio spanning across animal feed, crop protection, palm oil, and dairy, which account for 49%, 13%, 15%, and 14% of its revenue, respectively. The company's market-leading positions in agricultural inputs and outputs, strategic focus on less-regulated segments, and superior management and parentage make it an attractive investment opportunity in the agriculture industry. GODREJAGRO has a solid long-term track record of consistent growth and generates robust return ratios. Its well-diversified business portfolio, combined with its market dominance, sets it apart as a strong player in the sector.
Business Segments:
Feeds:
GODREJAGRO offers a range of animal feed products, including cattle feed, layer feed for chickens, and aqua feed for shrimp and fish. It holds the position of being the largest feed player in India with over 30 manufacturing plants and a total volume of 1.4 million metric tonnes. The feed industry is currently experiencing margin pressure, resulting in lower profitability, and the company's realizations per tonne decreased from an all-time high of Rs. 35,000 to Rs. 30,000 between June and December 2022.
GODREJAGRO is closely monitoring competition from agri-tech companies that have entered the market and launched their own animal feed products. However, the company is committed to increasing its volume growth and market share in this segment.
Crop Protection:
The Crop Protection segment of GODREJAGRO comprises both the Standalone crop protection business and Astec Lifesciences, in which the company holds a 66% stake. The portfolio of products includes Plant Growth Regulators, Organic Manures, Biostimulants and Crop Protection chemicals. The company has invested in backward integration to diversify its raw material sourcing and reduce dependence on international markets, resulting in benefits being realized. Astec LifeSciences has commercialized two new CDMO products during the year. However, realizations and export revenue have been affected recently.
The company is concentrating on the Contract Development and Manufacturing Organization (CDMO) part of the business to achieve sustainable and profitable growth, with a goal of doubling CDMO revenues this year and maintaining 30% to 50% growth year-on-year. To be immune to volatility, the strategy is to diversify and expand into higher margin products and the CDMO business.
Oil Palm:
GODREJAGRO holds the largest market share of palm oil production in India with 30% of the market. The company has a potential plantation area of 2,00,000 hectares and aims to increase it at a rate of 10,000 hectares per annum, from the current 3,000 to 4,000 hectares per annum. Despite the current steep fall in palm oil prices, the company is still generating high realizations as the prices of palm oil have seen a sharp rise in the post-Covid inflationary era. To insulate the business from the volatility in oil prices, Godrej Agrovet has made investments in a 400-ton refinery and a solvent extraction plant of 100 TPD.
Dairy:
GODREJAGRO's subsidiary Creamline Dairy Products Limited sells packaged milk and dairy products under the brand name "Jersey." The dairy segment witnessed an increase in volume growth for both milk volumes and value-added products; however, it was offset by a continuous rise in milk procurement prices. Currently, the segment is facing losses, and the management is looking to break even by achieving 50% revenue from value-added products.
Processed Foods & Poultry:
GODREJAGRO has a joint venture with Tyson India Holdings Limited, with a ratio of 51:49, to produce processed chicken and frozen foods. The products are marketed under the brands "Real Good Chicken" and "Yummiez". The company aims to increase its production capacity by 15-20% in the coming year. The company's major clients include HORECA, and it plans to grow its branded business with QSR and D2C companies to reduce volatility.
Business Performance:
GODREJAGRO reported strong business performance in Q3 FY2023 and the nine months of FY2023, with healthy topline growth of 12% and 17% year-on-year, respectively. The animal feed segment achieved the highest ever quarterly volumes in Q3 FY2023 with a 7% year-on-year volume growth, while the poultry segment recorded strong growth in both topline and profitability.
In terms of segment-wise performance, the vegetable oil segment registered 13% growth in Fresh Fruit Bunch volumes in Q3 FY2023. The dairy segment sustained volume growth in value-added products and milk volumes, but there was a continued rise in milk procurement prices. However, the crop protection business has experienced headwinds due to muted domestic demand and price erosion in the export market, while the Bangladesh business has been impacted by price controls on essential food commodities.
The supply chain efficiency and improvements in the production process have resulted in an improvement in Oil Extraction Ratio (OER) in the palm oil business. The company expects Crude Palm Oil (CPO) prices to rise slightly but not significantly.
Historical Revenue Mix:
Click here to check 10 Yr Financial X-Ray
| Company Name | CMP(₹) | |||||||
|---|---|---|---|---|---|---|---|---|
| Godrej Agrovet | 769.6 | 10.9 (1.4%) | Small Cap | 9,561 | 21.6 | 3.7 | 35.1 | 5.9 |
| Waterbase | 51.5 | 0.1 (0.2%) | Small Cap | 339 | -4.2 | -3.1 | - | 1.3 |
| Prima Agro | 23.2 | -1 (-4.3%) | Small Cap | 12.5 | -3.6 | 19.2 | - | 0.9 |
| Prima Industries | 23.5 | -1.2 (-5%) | Small Cap | 7.9 | -0.3 | 5.7 | - | 3.9 |
| Ajooni Biotech | - | 0 (0%) | Small Cap | 0 | - | - | - | - |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,795 | 4,298 | 4,911 | 5,186 | 5,918 | 6,965 | 6,268 | 8,306 | 9,374 | 9,561 |
| Operating Expenses ⓘ | 3,491 | 3,969 | 4,473 | 4,743 | 5,462 | 6,476 | 5,704 | 7,641 | 8,855 | 8,859 |
| Manufacturing Costs | 135 | 178 | 206 | 241 | 261 | 374 | 359 | 445 | 530 | 549 |
| Material Costs | 2,816 | 3,142 | 3,791 | 3,970 | 4,574 | 5,376 | 4,608 | 6,305 | 7,389 | 7,244 |
| Employee Cost | 147 | 168 | 233 | 276 | 294 | 354 | 376 | 439 | 453 | 539 |
| Other Costs ⓘ | 393 | 482 | 244 | 255 | 333 | 373 | 360 | 451 | 482 | 528 |
| Operating Profit ⓘ | 304 | 329 | 438 | 443 | 456 | 488 | 564 | 665 | 519 | 701 |
| Operating Profit Margin (%) | 8.0% | 7.6% | 8.9% | 8.5% | 7.7% | 7.0% | 9.0% | 8.0% | 5.5% | 7.3% |
| Other Income ⓘ | 15 | 55 | 59 | 32 | 53 | 47 | 40 | 80 | 111 | 41 |
| Interest ⓘ | 33 | 61 | 86 | 45 | 34 | 42 | 46 | 63 | 99 | 108 |
| Depreciation ⓘ | 46 | 62 | 75 | 86 | 98 | 148 | 154 | 173 | 185 | 214 |
| Exceptional Items ⓘ | 35 | -6 | 20 | 12 | 88 | -10 | 0 | -17 | 0 | 0 |
| Profit Before Tax ⓘ | 274 | 254 | 375 | 372 | 477 | 349 | 453 | 542 | 378 | 473 |
| Tax ⓘ | 63 | 69 | 102 | 121 | 128 | 48 | 106 | 122 | 82 | 113 |
| Profit After Tax | 211 | 185 | 273 | 251 | 349 | 301 | 348 | 419 | 295 | 359 |
| PAT Margin (%) | 5.6% | 4.3% | 5.6% | 4.8% | 5.9% | 4.3% | 5.5% | 5.0% | 3.2% | 3.8% |
| Adjusted EPS (₹) | 11.6 | 10.2 | 13.4 | 11.9 | 17.1 | 15.9 | 16.3 | 21.0 | 15.7 | 18.7 |
| Dividend Payout Ratio (%) | 16% | 22% | 0% | 38% | 26% | 35% | 49% | 45% | 60% | 53% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 541 | 663 | 1,007 | 1,410 | 1,646 | 1,834 | 2,047 | 2,263 | 2,332 | 2,510 |
| Share Capital ⓘ | 93 | 93 | 185 | 192 | 192 | 192 | 192 | 192 | 192 | 192 |
| Reserves ⓘ | 448 | 570 | 822 | 1,218 | 1,454 | 1,642 | 1,855 | 2,071 | 2,140 | 2,318 |
| Minority Interest | 0 | 133 | 254 | 269 | 401 | 382 | 410 | 420 | 406 | 404 |
| Debt | 332 | 939 | 660 | 403 | 388 | 618 | 943 | 1,501 | 1,230 | 1,261 |
| Long Term Debt | 114 | 46 | 21 | 14 | 64 | 43 | 149 | 47 | 55 | 293 |
| Short Term Debt | 218 | 892 | 639 | 389 | 324 | 576 | 794 | 1,454 | 1,176 | 968 |
| Trade Payables | 641 | 785 | 841 | 897 | 1,240 | 1,289 | 778 | 695 | 704 | 628 |
| Others Liabilities ⓘ | 298 | 531 | 446 | 556 | 555 | 549 | 602 | 677 | 771 | 864 |
| Total Liabilities ⓘ | 1,813 | 3,051 | 3,208 | 3,535 | 4,230 | 4,672 | 4,779 | 5,557 | 5,444 | 5,667 |
Fixed Assets | ||||||||||
| Gross Block | 834 | 1,670 | 1,610 | 1,718 | 2,389 | 2,624 | 2,891 | 3,163 | 3,502 | 3,938 |
| Accumulated Depreciation | 217 | 446 | 133 | 221 | 319 | 445 | 593 | 756 | 935 | 1,131 |
| Net Fixed Assetsⓘ | 616 | 1,225 | 1,477 | 1,496 | 2,070 | 2,178 | 2,298 | 2,407 | 2,568 | 2,806 |
| CWIP ⓘ | 175 | 126 | 50 | 190 | 94 | 153 | 141 | 90 | 204 | 192 |
| Investmentsⓘ | 90 | 95 | 175 | 195 | 117 | 129 | 124 | 160 | 158 | 177 |
| Inventories | 444 | 745 | 738 | 763 | 899 | 887 | 980 | 1,429 | 1,344 | 1,383 |
| Trade Receivables | 286 | 486 | 522 | 620 | 735 | 853 | 823 | 951 | 574 | 519 |
| Cash Equivalents | 17 | 41 | 62 | 32 | 30 | 51 | 51 | 35 | 30 | 53 |
| Others Assetsⓘ | 185 | 332 | 182 | 238 | 287 | 421 | 362 | 485 | 565 | 537 |
| Total Assets ⓘ | 1,813 | 3,051 | 3,208 | 3,535 | 4,230 | 4,672 | 4,779 | 5,557 | 5,444 | 5,667 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 78 | 159 | 897 | 354 | 448 | 240 | -10 | -120 | 874 | 678 |
| PBT ⓘ | 274 | 254 | 375 | 372 | 477 | 349 | 453 | 542 | 378 | 473 |
| Adjustment ⓘ | 48 | 94 | 91 | 113 | 17 | 208 | 190 | 200 | 198 | 282 |
| Changes in Working Capital ⓘ | -186 | -140 | 512 | -47 | 63 | -220 | -541 | -709 | 392 | 47 |
| Tax Paid ⓘ | -58 | -48 | -80 | -84 | -110 | -97 | -112 | -153 | -93 | -124 |
| Cash Flow From Investing Activity ⓘ | -175 | -520 | -63 | -253 | -237 | -255 | -179 | -208 | -284 | -327 |
| Capex | -154 | -156 | -195 | -245 | -241 | -258 | -241 | -268 | -279 | -377 |
| Net Investments | -13 | -304 | 87 | -5 | -5 | 0 | -1 | -17 | 7 | 0 |
| Others ⓘ | -8 | -59 | 45 | -3 | 8 | 3 | 63 | 76 | -12 | 49 |
| Cash Flow From Financing Activityⓘ | -7 | 369 | -812 | -125 | -217 | 36 | 189 | 311 | -594 | -328 |
| Net Proceeds from Shares ⓘ | 0 | 4 | 0 | 317 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | -92 | -15 | -43 | -11 | 10 | -17 | 139 | -82 | 34 | 195 |
| Interest Paid ⓘ | -35 | -60 | -86 | -45 | -35 | -39 | -43 | -60 | -96 | -101 |
| Dividend Paid ⓘ | -71 | -45 | 0 | -87 | -89 | -89 | -112 | -159 | -184 | -184 |
| Others ⓘ | 191 | 486 | -683 | -299 | -102 | 182 | 205 | 612 | -349 | -237 |
| Net Cash Flow ⓘ | -104 | 9 | 22 | -24 | -6 | 21 | 0 | -17 | -5 | 23 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 39.05 | 30.69 | 32.69 | 20.77 | 22.86 | 17.27 | 17.91 | 19.45 | 12.86 | 14.85 |
| ROCE (%) | 31.75 | 22.77 | 26.56 | 23.87 | 26.43 | 17.24 | 18.1 | 17.59 | 12.73 | 15.51 |
| Asset Turnover Ratio | 2.09 | 1.77 | 1.57 | 1.54 | 1.59 | 1.61 | 1.37 | 1.66 | 1.76 | 1.79 |
| PAT to CFO Conversion(x) | 0.37 | 0.86 | 3.29 | 1.41 | 1.28 | 0.8 | -0.03 | -0.29 | 2.96 | 1.89 |
| Working Capital Days | ||||||||||
| Receivable Days | 27 | 33 | 37 | 40 | 40 | 40 | 47 | 38 | 29 | 20 |
| Inventory Days | 43 | 50 | 55 | 53 | 49 | 45 | 53 | 51 | 52 | 50 |
| Payable Days | 29 | 32 | 31 | 32 | 30 | 26 | 36 | 34 | 34 | 34 |
The company was incorporated as Godrej Agrovet Private Limited on November 25, 1991 in the state of Gujarat as a private limited company under the Companies Act, 1956. The company became a deemed public limited company under Section 43A(1) of the Companies Act, 1956, and the word “private” was struck off from the name of the company with effect from April 27, 1992. Pursuant to the company passing a resolution under Section 21 of the Companies Act, 1956, the company was registered as a public limited company with effect from August 26, 1994. Subsequently, the Registrar of Companies, Gujarat issued a fresh certificate of incorporation dated February 19, 2002 consequent upon conversion, recording the change of the company’s name to ‘Godrej Agrovet Limited’.
The company is focused on improving productivity of farmers by innovating products and services that sustainably increase crop and livestock yields. It has made significant investments to enhance its R&D capabilities over the years . The company has two dedicated R&D centres for its crop protection business at Mumbai and Thane, which has enabled the company to launch new products. Its oil palm business has a dedicated R&D center at Andhra Pradesh, which is focused on improving the yield performance of oil palm crop and exploring new avenues of value creation from oil palm biomass.
Business area of the company
The company is a diversified, research and development focused agri-business company with operations across five business verticals i.e. animal feed, crop protection, oil palm, dairy, and poultry and processed foods.
Awards and Accreditations
Major events and milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
100% Secure Process
Account Discovery
- OTP from CAMS
Account Linking for Stocks & MF
- One OTP per link Eg. NSDL, CDSL, CAMS, KFin etc.
One Click Upload for your Current Portfolio and Future Transactions!
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
